Publications
7/11/11 Weekly Briefing: Expiration Week: To Roll or Not to Roll?
Jim monitors the Portfolio’s three July options positions approaching expiration. He also cautions against fear of a double dip recession.
7/7/11 Trade Alert: A Really Cheap Drug Stock–UPDATE
(updated with trade rationale) Sell Put Credit Spread on Amgen (Nasdaq: AMGN) “Buy to Open” August $52.50 Put and “Sell to Open” August $57.50 Put Option Symbols: AMGN110820P52.5 and AMGN110820P57.5 Limit Order Price: Net credit of $1.25 or more ($125 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More
7/05/11 Weekly Briefing: Diagonal Spreads
Jim thinks that last week’s stock market rally is a sign of better things to come. He also explains why diagonal spreads offer both higher returns–and higher risks–than our bread-and-butter vertical spreads.
6/30/11 Trade Alert: Consumer Products Giant is Raising Prices–UPDATE
(updated with trade rationale) Sell Put Credit Spread on Procter & Gamble (NYSE: PG) “Buy to Open” August $57.50 Put and “Sell to Open” August $62.50 Put Option Symbols: PG110820P57.5 and PG110820P62.5 Limit Order Price: Net credit of $1.25 or more ($125 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for […]… Read More
6/27/11 Weekly Briefing: Benefiting from Time Decay a Second Way
Jim uses the dark art of technical analysis to downplay the chances of a severe stock market decline and delves deep into the time-value decay benefits of horizontal spreads…. Read More
6/23/11 Trade Alert: Playing a Small Business Recovery–UPDATE
(updated with trade rationale) Sell Put Credit Spread on Intuit (NasdaqGS: INTU) “Buy to Open” October $38 Put and “Sell to Open” October $48 Put Option Symbols: INTU111022P38 and INTU111022P48 Limit Order Price: Net credit of $1.70 or more ($170 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More
6/21/11 Weekly Briefing: The Virtues of Diversification
The recent market correction won’t morph into a more serious downturn. Nevertheless, a diversified portfolio of options can protect you from any outcome in the markets…. Read More
6/16/11 Trade Alert: High-Growth Cancer Drug Stock–UPDATE
(updated with trade rationale) Sell Put Credit Spread on Celgene (NasdaqGS: CELG) “Buy to Open” October $45 Put and “Sell to Open” October $55 Put Option Symbols: CELG111022P45 and CELG111022P55 Limit Order Price: Net credit of $1.80 or more ($180 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More
6/13/11: Weekly Briefing: Trading Options from a Stock Perspective
Understanding underlying company fundamentals is as important with option investing as it is with straight equities. Here, too, short-term market fluctuations often provide opportunities to establish value-based positions in good businesses…. Read More
6/9/11 Trade Alert: Bullish on Two Megatrends–UPDATE
The first tech stock is added to the Options for Income Growth Portfolio and a conservative income bet on health care rounds out this double-recommendation week.
… Read More
« Previous 1 … 395 396 397 398 399 … 406 Next »
Search Jim Fink Investing

If you are an existing Jim Fink subscriber and this is your first time visiting this site, please CLICK HERE to create your account.
If you are a Jim Fink subscriber that has already created an account, you can access your account by clicking HERE.
Questions about your account? Please contact Jim Fink Customer Service at 1-202-978-3606 or by email at CustomerService@JimFinkInvesting.com